IRADIMED CORPORATION - COMMON STOCK

IRADIMED CORPORATION Named a 2023 Best Small Company in America by Forbes

10 May 2023 08:30:00 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Announces First Quarter 2023 Financial Results

04 May 2023 08:30:01 By Nasdaq GlobeNewswire

IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th

27 Apr 2023 08:30:01 By Nasdaq GlobeNewswire

IRADIMED CORPORATION To Present at the 35th Annual Roth Conference

06 Mar 2023 08:45:00 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Issues Urgent Medical Device Correction

24 Feb 2023 16:15:00 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend

02 Feb 2023 08:00:01 By Nasdaq GlobeNewswire

IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd

26 Jan 2023 10:30:00 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022

18 Jan 2023 08:00:01 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results

03 Nov 2022 07:00:01 By Nasdaq GlobeNewswire

IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd

27 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA

10 Oct 2022 08:00:00 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel to Board of Directors

06 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results

29 Jul 2022 11:00:10 By Nasdaq GlobeNewswire

UPDATE - IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

28 Jul 2022 13:56:57 By Nasdaq GlobeNewswire

IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

22 Jul 2022 16:30:00 By Nasdaq GlobeNewswire

IRADIMED Names John F. Glenn Chief Financial Officer

26 May 2022 16:05:00 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Announces First Quarter 2022 Financial Results

29 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

IRADIMED CORPORATION Announces Executive Transition

28 Apr 2022 16:00:00 By Nasdaq GlobeNewswire

IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th

05 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

IRADIMED Announces Special $1.00 Per Share Cash Dividend

07 Feb 2022 16:05:00 By Nasdaq GlobeNewswire